Dr Troy McCall has re-joined Premier Research as the new chief operating officer (COO) and reporting to CEO Dr Simon Yaxley, he will now assume responsibility for all aspects of the company's worldwide clinical research operations.

Prior to accepting the post McCall held the position of president and CEO of data management platform provider Advanced Clinical Research Services (ACRS), and also served as vice president of Business Development for Premier Research

Albany Molecular Research has created the new position of vice president of pharmaceutical development and manufacturing and recruited Jonathan Evans, previously of General Electric's Advanced Materials Division, to fill the role.

Reporting to the chairman, president and CEO Thomas D'Ambra, Evans will now assume responsibility for Albany's Chemical Development, Small Scale cGMP Manufacturing, Analytical, Quality Control Quality Assurance, and Large Scale Commercial Manufacturing business components.

Anapharm, a contract research organisation (CRO) owned by PharmaNet, has seen Dr Jean-Marie Houle recently join as the vice president of Clinical Operations.

Houle has19 years experience in the design, implementation and management of pre-clinical R&D and clinical Phase I-III studies.

Parexel's eClinical software subsidiary Perceptive Informatics has appointed Sina Adibi to the positions of vice president of Software Development and chief technology officer and will be responsible for all of Perceptive's software development and strategic direction.

India's Ranbaxy Laboratories has announced that, Dr Himadri Sen will be joining the company as President of R&D. Prior to the appointment the firm had also Atul Sobti to COO status and Peter Burema to the job of president of Global Pharmaceutical Business.

Privately-held Hyaluron Contract Manufacturing has promoted Paul Souza to the chief financial officer position, with responsibility for all financial operations, including investor relations.